{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:09:21Z","timestamp":1792008561314,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019637","name":"Horizon Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.amjmed.2021.07.025","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T04:53:13Z","timestamp":1629262393000},"page":"32-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3156-3418","authenticated-orcid":false,"given":"Philip C.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Pillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0492-0712","authenticated-orcid":false,"given":"Vangelis","family":"Karalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8406-4121","authenticated-orcid":false,"given":"Eleni","family":"Karatza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-8883","authenticated-orcid":false,"given":"David","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0245","authenticated-orcid":false,"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-2112","authenticated-orcid":false,"given":"Jan H.","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2191-1607","authenticated-orcid":false,"given":"Peter L.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2226-538X","authenticated-orcid":false,"given":"Mark","family":"Nidorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.amjmed.2021.07.025_bib0001","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine and the heart","volume":"42","author":"Imazio","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2021.07.025_bib0002","series-title":"A Treatise on Gout","author":"Duckworth","year":"1889"},{"issue":"3","key":"10.1016\/j.amjmed.2021.07.025_bib0003","first-page":"495","article-title":"Review: systemic toxicity associated with the intravenous administration of colchicine\u2013guidelines for use","volume":"15","author":"Wallace","year":"1988","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.amjmed.2021.07.025_bib0004","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.amjmed.2021.07.025_bib0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/clpt.1993.161","article-title":"Colchicine disposition in human leukocytes after single and multiple oral administration","volume":"54","author":"Chappey","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.amjmed.2021.07.025_bib0006","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today","volume":"73","author":"Niel","year":"2006","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.amjmed.2021.07.025_bib0007","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00194404","article-title":"Pharmacokinetics and absolute bioavailability of colchicine after I.V. and oral administration in healthy human volunteers and elderly subjects","volume":"46","author":"Rochdi","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.amjmed.2021.07.025_bib0008","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11926-002-0073-2","article-title":"Update on colchicine and its mechanism of action","volume":"4","author":"Molad","year":"2002","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.amjmed.2021.07.025_bib0009","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/00498254.2021.1909782","article-title":"Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens","volume":"51","author":"Karatza","year":"2021","journal-title":"Xenobiotica"},{"issue":"7","key":"10.1016\/j.amjmed.2021.07.025_bib0010","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1517\/17425255.2014.915027","article-title":"Pharmacokinetics considerations for gout treatments","volume":"10","author":"Richette","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"9","key":"10.1016\/j.amjmed.2021.07.025_bib0011","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3109\/0886022X.2011.605980","article-title":"Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients","volume":"33","author":"Ozen","year":"2011","journal-title":"Ren Fail"},{"issue":"10","key":"10.1016\/j.amjmed.2021.07.025_bib0012","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1248\/bpb.b20-00314","article-title":"Prescription of colchicine with other dangerous concomitant medications: a nation-wide survey using the Japanese claims database","volume":"43","author":"Imai","year":"2020","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"10.1016\/j.amjmed.2021.07.025_bib0013","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4078\/jrd.2014.21.6.314","article-title":"A case of high dose colchicine with no efficacy in a patient with chronic kidney disease taking rifampicin","volume":"21","author":"Koo","year":"2014","journal-title":"J Rheum Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2021.07.025_bib0014","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.1840110209","article-title":"The effect of liver dysfunction on colchicine pharmacokinetics in the rat","volume":"11","author":"Leighton","year":"1990","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.amjmed.2021.07.025_bib0015","first-page":"710","article-title":"Colchicine disposition in patients with familial Mediterranean fever with renal impairment","volume":"21","author":"Ben-Chetrit","year":"1994","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.amjmed.2021.07.025_bib0016","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine update: 2008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.amjmed.2021.07.025_bib0017","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1002\/art.30557","article-title":"Colchicine dose reduction in patients with normal liver and kidney function: comment on the article by Terkeltaub et\u00a0al","volume":"63","author":"Ben-Chetrit","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.amjmed.2021.07.025_bib0018","first-page":"264","article-title":"Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout","volume":"18","author":"Wallace","year":"1991","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.amjmed.2021.07.025_bib0019","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2021.07.025_bib0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/431592","article-title":"Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study","volume":"41","author":"Hung","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2021.07.025_bib0021","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.amjmed.2015.02.020","article-title":"Colchicine toxicity: an exaggerated reality?","volume":"128","author":"Solak","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2021.07.025_bib0022","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjmed.2021.07.025_bib0023","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2014update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2021.07.025_bib0024","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.cmet.2019.03.011","article-title":"Choline uptake and metabolism modulate macrophage IL-1\u03b2 and IL-18 production","volume":"29","author":"Sanchez-Lopez","year":"2019","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.amjmed.2021.07.025_bib0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2014-206074","article-title":"AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages","volume":"75","author":"Wang","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2021.07.025_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018993","article-title":"Colchicine inhibits neutrophil extracellular trap Formation in patients with acute coronary syndrome after percutaneous coronary intervention","volume":"10","author":"Vaidya","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.amjmed.2021.07.025_bib0027","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/rheumatology\/kex222","article-title":"Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase","volume":"56","author":"Knieper","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.amjmed.2021.07.025_bib0028","doi-asserted-by":"crossref","unstructured":"Ahn SM, Oh JS, Hong S, Lee C-K, Yoo B, Kim Y-G. Comparative efficacy of low-dose versus regular-dose colchicine to prevent flares in gout patients initiated on urate-lowering therapies [e-pub ahead of print]. Rheumatology. doi: 10.1093\/rheumatology\/keab303.","DOI":"10.1093\/rheumatology\/keab303"},{"issue":"16","key":"10.1016\/j.amjmed.2021.07.025_bib0029","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.amjmed.2021.07.025_bib0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.1016\/j.amjmed.2021.07.025_bib0031","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.amjmed.2021.07.025_bib0032","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"7293","key":"10.1016\/j.amjmed.2021.07.025_bib0033","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.amjmed.2021.07.025_bib0034","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jacl.2020.07.003","article-title":"Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability","volume":"14","author":"Nidorf","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"28","key":"10.1016\/j.amjmed.2021.07.025_bib0035","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/eurheartj\/ehab276","article-title":"Coronary artery disease: \u201cgout\u201d in the artery?","volume":"42","author":"Strandberg","year":"2021","journal-title":"Eur Heart J"},{"issue":"28","key":"10.1016\/j.amjmed.2021.07.025_bib0036","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and metaanalysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.amjmed.2021.07.025_bib0037","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.amjmed.2021.01.019","article-title":"The use of colchicine in cardiovascular diseases: a systemic review","volume":"134","author":"Siak","year":"2021","journal-title":"Am J Med"},{"issue":"21","key":"10.1016\/j.amjmed.2021.07.025_bib0038","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American heart association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.amjmed.2021.07.025_bib0039","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.amjmed.2021.07.025_bib0040","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/annrheumdis-2015-207984","article-title":"Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims","volume":"75","author":"Solomon","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2021.07.025_bib0041","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0049-0172(91)90019-V","article-title":"Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years","volume":"20","author":"Ben-Chetrit","year":"1991","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.amjmed.2021.07.025_bib0042","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2459\/JCM.0000000000001157","article-title":"Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials","volume":"22","author":"Andreis","year":"2021","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"10.1016\/j.amjmed.2021.07.025_bib0043","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","article-title":"Adverse events during oral colchicine use: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Stewart","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.amjmed.2021.07.025_bib0044","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semarthrit.2020.11.007","article-title":"A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections","volume":"51","author":"McEwan","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.amjmed.2021.07.025_bib0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/096032719601501104","article-title":"Markedly altered colchicine kinetics in a fatal intoxication: examination of contributing factors","volume":"15","author":"Borron","year":"1996","journal-title":"Hum Exp Toxicol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321005106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321005106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:29:52Z","timestamp":1762079392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934321005106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0002934321005106"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.07.025","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}